Novartis drug cuts recurrence risk by 25% in early-stage breast cancer
By Ludwig Burger FRANKFURT (Reuters) - Novartis breast cancer drug Kisqali cut the risk of…
By Ludwig Burger FRANKFURT (Reuters) - Novartis breast cancer drug Kisqali cut the risk of…
By Brendan Pierson (Reuters) -Johnson & Johnson on Wednesday faced the first trial in…
(Reuters) -Pfizer Inc is planning to raise $31 billion through its largest debt offering…
By Michael Erman (Reuters) -Merck & Co said on Sunday it will buy Prometheus…
By Sheila Dang (Reuters) - Twitter-owner Elon Musk has said advertisers are returning to…
By Dietrich Knauth and Mike Spector (Reuters) -Johnson & Johnson’s second attempt to…
By Julie Steenhuysen CHICAGO (Reuters) - The U.S. National Institute on Aging (NIA) is…
Welcome, Login to your account.
Welcome, Create your new account
A password will be e-mailed to you.